|
A new analytical
technique called proteomics could
greatly improve the accuracy of breast cancer diagnosis, according
to a report in the British Journal of Cancer
British and
Swedish researchers have become the first to use the technique
-- which analyzes the protein molecules produced by our genes
-- to identify patterns or "fingerprints" distinctive
to breast cancer.
The researchers
believe proteomics has the potential to be a significant improvement
on current diagnosis techniques, which rely on pathologists studying
samples of breast tissue under the microscope to visually spot
abnormal cells.
Researchers
from the University of Westminster and the Karolinska Institute
in Sweden used proteomics to analyze 32 samples of breast tissue,
measuring the levels of hundreds of types of protein to develop
a protein molecular signature.
Analyzing
the results with statistical software, they reported that they
were able to separate breast cancer specimens from healthy tissue
and benign lumps.
"In the
past we've only been able to look at a handful of proteins at
the same time, but using proteomics, we can examine a tissue sample
for hundreds, possibly even thousands, of proteins at once,"
reported researcher Dr. Miriam Dwek.
"The
technique still needs to be further developed and validated in
larger studies, but it has the potential to be rolled out to pathology
labs throughout the country and to significantly improve cancer
diagnosis," Dwek added.
Other
Sources: British Journal of Cancer
|